{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:44:16Z","timestamp":1788137056734,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T00:00:00Z","timestamp":1728777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.metop.2024.100325","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T09:36:32Z","timestamp":1729244192000},"page":"100325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploring the epidemiology and awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among health sciences students in an academic health care institute in India"],"prefix":"10.1016","volume":"24","author":[{"given":"Umasankari","family":"S.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Aishwarya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"Aishwarya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivangi","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.B.","family":"Pavithra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumili","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.M.","family":"Vinodhini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metop.2024.100325_bib1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/MEG.0000000000001235","article-title":"Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies","volume":"30","author":"Tomic","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.metop.2024.100325_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/gastro\/gov047","article-title":"Perceptions of non-alcoholic fatty liver disease \u2013 an Asian community-based study","volume":"4","author":"Goh","year":"2016","journal-title":"Gastroenterology Report"},{"key":"10.1016\/j.metop.2024.100325_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/DMSO.S189544","article-title":"The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011","volume":"12","author":"Khang","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.metop.2024.100325_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gtc.2019.09.007","article-title":"Burden of disease due to nonalcoholic fatty liver disease","volume":"49","author":"Muthiah","year":"2020","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.metop.2024.100325_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.metop.2024.100325_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/tgh.2019.11.14","article-title":"Non-invasive diagnosis: non-alcoholic fatty liver disease and alcoholic liver disease","volume":"5","author":"Altamirano","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.metop.2024.100325_bib7","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.metop.2024.100325_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/liv.15852","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa","volume":"44","author":"Younossi","year":"2024","journal-title":"Liver Int"},{"issue":"20","key":"10.1016\/j.metop.2024.100325_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015473","article-title":"Metabolic-dysfunction-associated steatotic liver disease-its pathophysiology, association with atherosclerosis and cardiovascular disease, and treatments","volume":"24","author":"Yanai","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metop.2024.100325_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cgh.2021.05.002","article-title":"Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"20","author":"Orci","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.metop.2024.100325_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.14218\/JCTH.2021.00586","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: current progresses and challenges","volume":"10","author":"Teng","year":"2022","journal-title":"J Clin Transl Hepatol"},{"issue":"6","key":"10.1016\/j.metop.2024.100325_bib12","first-page":"1","article-title":"Cross-sectional study on adherence and barriers to healthy lifestyle habits in Indian population","volume":"18","author":"Madhav","year":"2024","journal-title":"Oncology and Radiotherapy"},{"key":"10.1016\/j.metop.2024.100325_bib13","first-page":"32","article-title":"COVID-19: knowledge, risk perception and strategies for handling the pandemic","volume":"153","year":"2020","journal-title":"F\u00fchrer A, Frese T, Karch A, et al. Z Evid Fortbild Qual Gesundhwes"},{"key":"10.1016\/j.metop.2024.100325_bib14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1007\/s00125-016-3952-1","article-title":"Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions","volume":"59","year":"2016","journal-title":"Cusi K. Diabetologia"},{"issue":"5","key":"10.1016\/j.metop.2024.100325_bib15","article-title":"Metabolic syndrome in type 2 diabetes mellitus patients: prevalence, risk factors, and associated microvascular complications","volume":"15","author":"Asghar","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.metop.2024.100325_bib16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.metop.2024.100325_bib17","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1007\/s10620-015-3821-7","article-title":"Hepatocellular carcinoma in the setting of non-cirrhotic nonalcoholic fatty liver disease and the metabolic syndrome: US experience","volume":"60","author":"Perumpail","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.metop.2024.100325_bib18","first-page":"603","article-title":"Nonalcoholic fatty liver disease: common questions and answers on diagnosis and management","volume":"15","author":"Westfall","year":"2020","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.metop.2024.100325_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/gastro\/gov047","article-title":"Perceptions of non-alcoholic fatty liver disease - an Asian community-based study","volume":"4","author":"Goh","year":"2016","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"1","key":"10.1016\/j.metop.2024.100325_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dsi23-0010","article-title":"Understanding the burden of nonalcoholic fatty liver disease: time for action","volume":"37","author":"Younossi","year":"2024","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.metop.2024.100325_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.diabres.2008.11.039","article-title":"Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome","volume":"84","author":"Mohan","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metop.2024.100325_bib22","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.18203\/2349-3291.ijcp20171726","article-title":"Prevalence of non-alcoholic fatty liver disease among obese children in North Kerala, India","volume":"4","author":"Reetha","year":"2017","journal-title":"Int J Contemp Pediatr"},{"issue":"1","key":"10.1016\/j.metop.2024.100325_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92292-y","article-title":"High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects","volume":"11","author":"Higashiura","year":"2021","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.metop.2024.100325_bib24","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.3390\/jcm12196216","article-title":"Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: the patient and physician perspective","volume":"12","author":"Eskridge","year":"2023","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.metop.2024.100325_bib25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jhep.2016.06.005","article-title":"MRI and MRE for non\u2010invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice HHS public access","volume":"65","author":"Dulai","year":"2016","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.metop.2024.100325_bib26","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1002\/jmri.27703","article-title":"Assessment of imaging modalities against liver biopsy in nonalcoholic fatty liver disease: the Amsterdam NAFLD-NASH cohort","volume":"54","author":"Troelstra","year":"2021","journal-title":"J Magn Reson Imag"},{"issue":"2","key":"10.1016\/j.metop.2024.100325_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/osp4.751","article-title":"Non-alcoholic fatty liver modifies associations of body mass index and waist circumference with cardiometabolic risk: the CARDIA study","volume":"10","author":"Mathew","year":"2024","journal-title":"Obes Sci Pract"},{"issue":"1","key":"10.1016\/j.metop.2024.100325_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/2230-8210.91187","article-title":"Metabolic syndrome in south asians","volume":"16","author":"Pandit","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.metop.2024.100325_bib29","article-title":"Perception of non-alcoholic fatty liver disease: real-life experience from Pakistan","volume":"13","author":"Butt","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.metop.2024.100325_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100638","article-title":"Emerging therapies for MASLD and their impact on plasma lipids","volume":"17","author":"Nguyen","year":"2024","journal-title":"Am J Prev Cardiol"},{"issue":"3","key":"10.1016\/j.metop.2024.100325_bib31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/jc.2015-3444","article-title":"Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies","volume":"101","author":"Loomis","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.metop.2024.100325_bib32","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.3390\/healthcare11192696","article-title":"Interactions between metabolic syndrome, MASLD, and arterial stiffening: a single-center cross-sectional study","volume":"11","author":"Solomon","year":"2023","journal-title":"Healthcare"},{"issue":"2","key":"10.1016\/j.metop.2024.100325_bib33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ueg2.12508","article-title":"Exploring the links between types 2 diabetes and liver-related complications: a comprehensive review","volume":"12","author":"Otero","year":"2024","journal-title":"United European Gastroenterol J"},{"issue":"1","key":"10.1016\/j.metop.2024.100325_bib34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/jcm13010278","article-title":"What is new in metabolic dysfunction-associated steatotic liver disease in lean individuals: from bench to bedside","volume":"13","author":"Danpanichkul","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.metop.2024.100325_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7150\/ijbs.30121","article-title":"Role of nutrition in the pathogenesis and prevention of non-alcoholic fatty liver disease: recent updates","volume":"15","author":"Ullah","year":"2019","journal-title":"Int J Biol Sci"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936824000574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936824000574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T11:54:47Z","timestamp":1733918087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589936824000574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"alternative-id":["S2589936824000574"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2024.100325","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the epidemiology and awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among health sciences students in an academic health care institute in India","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2024.100325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100325"}}